Summary
Johnson & Johnson (JNJ) filed an 8-K on April 28, 2026, detailing the outcomes of its 2026 Annual Meeting of Shareholders held on April 23, 2026. The report indicates strong shareholder support for the company's slate of director nominees and its executive compensation practices. All 12 director nominees were elected to the Board of Directors, and the executive compensation, as described in the proxy statement, was approved on an advisory basis. Additionally, shareholders ratified the appointment of PricewaterhouseCoopers LLP as the company's independent registered public accounting firm for fiscal year 2026, reflecting confidence in the company's governance and financial oversight. Notably, a shareholder proposal seeking to adopt a policy requiring an independent board chair was not approved. This outcome suggests that the current board structure and leadership model are favored by the majority of JNJ's shareholders. The detailed voting results for each item are provided in the filing, offering transparency into shareholder sentiment on key governance matters.
Key Highlights
- 1All 12 director nominees were elected to the Johnson & Johnson Board of Directors, demonstrating broad shareholder confidence in the company's leadership.
- 2Shareholders approved, on an advisory basis, the executive compensation philosophy and the compensation of named executive officers ('Say on Pay'), indicating support for the company's compensation strategy.
- 3The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2026 was ratified by shareholders.
- 4A shareholder proposal to adopt a policy requiring an independent board chair was not approved, reflecting shareholder preference for the current board structure.
- 5The filing provides detailed voting results for director elections, executive compensation, auditor ratification, and the shareholder proposal.